Stock Insiders: NGS are reaching new heights with a clinically tested nutritional supplement

Stock Insiders is a new podcast series focused on investing and hosted by renowned business journalist Oriel Morrison. The program is sponsored by Barclay Pearce Capital, Australia’s leading corporate advisory and equities trading firm. 

In this episode Oriel chats to David Fenlon, non-executive chairman at Nutritional Growth Solutions (ASX:NGS).

Nutritional Growth Solutions is a global nutritional health company, working to ensure children reach their potential height through their scientifically-formulated, clinically-proven and patented products. NGS develops, produces and sells clinically tested nutritional supplement formulae for children.

The company just delivered a milestone quarter, with quarterly revenue of US$631K, up by 10% compared with December 2021.

Tune in below.